Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?"

Affiliations

Editorial

Mohmmed Tauseef Sharip et al. Inflamm Bowel Dis. 2025.

. 2025 Feb 10;31(2):614-615.

doi: 10.1093/ibd/izae242.

¹ Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

No abstract available

Comment in

Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862
DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease.
Bayoumy AB, Derijks LJJ, de Boer NKH. Bayoumy AB, et al. Inflamm Bowel Dis. 2025 Feb 10;31(2):612-613. doi: 10.1093/ibd/izae234. Inflamm Bowel Dis. 2025. PMID: 39446572 No abstract available.

Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862
DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease.
Bayoumy AB, Derijks LJJ, de Boer NKH. Bayoumy AB, et al. Inflamm Bowel Dis. 2025 Feb 10;31(2):612-613. doi: 10.1093/ibd/izae234. Inflamm Bowel Dis. 2025. PMID: 39446572 No abstract available.